The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 24, Issue 7, Pages 381-398
Publisher
Future Medicine Ltd
Online
2023-05-24
DOI
10.2217/pgs-2023-0043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
- (2023) Jesse J Swen et al. LANCET
- The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing
- (2023) Khalifa Alrajeh et al. PHARMACOGENOMICS
- The frequency of rs2231142 in ABCG2 among Native Hawaiian and Pacific Islander subgroups: implications for personalized rosuvastatin dosing
- (2023) Ola AlAzzeh et al. PHARMACOGENOMICS
- The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2 , and CYP2C9 and statin‐associated musculoskeletal symptoms
- (2022) Rhonda M. Cooper‐DeHoff et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prevalence of statin intolerance: a meta-analysis
- (2022) Ibadete Bytyçi et al. EUROPEAN HEART JOURNAL
- Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care
- (2022) Barbara S. Wiggins et al. PHARMACOTHERAPY
- The Association between ABCG2 421C>A (rs2231142) Polymorphism and Rosuvastatin Pharmacokinetics: A Systematic Review and Meta-Analysis
- (2022) Yubin Song et al. Pharmaceutics
- PharmVar GeneFocus : SLCO1B1
- (2022) Laura B. Ramsey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The frequency of major CYP2C19 genetic polymorphisms in women of Asian, Native Hawaiian and Pacific Islander subgroups
- (2022) Khalifa Y Alrajeh et al. Personalized Medicine
- Progression of precision statin prescribing for reduction of statin-associated muscle symptoms
- (2022) Natasha J Petry et al. PHARMACOGENOMICS
- The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data
- (2022) Yitian Zhou et al. PHARMACOGENOMICS JOURNAL
- Chromosomal and gonadal sex drive sex differences in lipids and hepatic gene expression in response to hypercholesterolemia and statin treatment
- (2022) Carrie B. Wiese et al. Biology of Sex Differences
- The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis
- (2021) Faven Butler et al. Journal of Personalized Medicine
- An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine
- (2021) Michelle Whirl‐Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- PharmVar GeneFocus: CYP2C9
- (2021) Katrin Sangkuhl et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Ensembl 2022
- (2021) Fiona Cunningham et al. NUCLEIC ACIDS RESEARCH
- The United States 2020 Census data: implications for precision medicine and the research landscape
- (2021) Youssef Roman Personalized Medicine
- Health Disparities of Cardiometabolic Disorders Among Filipino Americans: Implications for Health Equity and Community-Based Genetic Research
- (2021) Gerald Coronado et al. Journal of Racial and Ethnic Health Disparities
- The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort
- (2020) Youssef Roman et al. CLINICAL RHEUMATOLOGY
- Population structure and pharmacogenomic risk stratification in the United States
- (2020) Shashwat Deepali Nagar et al. BMC BIOLOGY
- Pharmacogenetics of statins treatment: Efficacy and safety
- (2019) Zi‐Wan Guan et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study
- (2019) Nancy P. Gordon et al. BMC PUBLIC HEALTH
- Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research
- (2018) Rachel Huddart et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A comprehensive analysis of the association of common variants of ABCG2 with gout
- (2017) Kuang-Hui Yu et al. Scientific Reports
- Dyslipidemia in Special Ethnic Populations
- (2016) Jia Pu et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Assessment of genetic polymorphisms associated with hyperuricemia or gout in the Hmong
- (2016) Youssef M Roman et al. Personalized Medicine
- Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
- (2015) Bruce K. Birmingham et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Individual and Combined Associations of Genetic Variants in CYP3A4, CYP3A5, and SLCO1B1 With Simvastatin and Simvastatin Acid Plasma Concentrations
- (2015) Jasmine A. Luzum et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans
- (2015) Katarzyna Drozda et al. Pharmacogenetics and Genomics
- Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review
- (2014) William J. Canestaro et al. GENETICS IN MEDICINE
- An assessment by the Statin Muscle Safety Task Force: 2014 update
- (2014) Robert S. Rosenson et al. Journal of Clinical Lipidology
- Racial/Ethnic Differences in Dyslipidemia Patterns
- (2013) Ariel T.H. Frank et al. CIRCULATION
- Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
- (2013) Rajiv Chowdhury et al. EUROPEAN HEART JOURNAL
- Statin-induced myopathy: a review and update
- (2011) Thura T Abd et al. Expert Opinion On Drug Safety
- Combined Influence of LDLR and HMGCR Sequence Variation on Lipid-Lowering Response to Simvastatin
- (2010) Lara M. Mangravite et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cardiovascular Risk Factors among Asian Americans: Results from a National Health Survey
- (2009) Jiali Ye et al. ANNALS OF EPIDEMIOLOGY
- Genetic Variations of the SLCO1B1 Gene in the Chinese, Malay and Indian Populations of Singapore
- (2009) Woon Fei Ho et al. Drug Metabolism and Pharmacokinetics
- Race does not explain genetic heterogeneity in pharmacogenomic pathways
- (2008) Jane L Yen-Revollo et al. PHARMACOGENOMICS
- Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations
- (2007) Eun-Young Kim et al. CLINICA CHIMICA ACTA
- Frequency of cytochrome P450 2C9 mutant alleles in a Korean population
- (2003) Young-Ran Yoon et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started